Antiretroviral News and Research

RSS

WHO recommends the use of first long-acting option to protect women from HIV

The first long-acting option to protect women from HIV, proven to reduce women's HIV risk, has been recommended for use by the World Health Organization.

1 Dec 2021

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

A new study uncovered large and persistent disparities by sex and age in the uptake of a preferred HIV medication in low- and middle-income countries, potentially subjecting some women to worse HIV treatment outcomes if the situation is not corrected quickly.

30 Nov 2021

Scientists identify a new therapeutic target for HIV

Scientists in Montreal and London have identified the key role played by transcription factorRORC2 in HIV infection: the molecule attaches itself to parts of the virus's genome yet doesn't prevent it from replicating.

30 Nov 2021

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.

30 Nov 2021

Research finds low global HIV viral suppression rates among children and adolescents

Globally, less than two thirds of children living with HIV who are taking treatment are 'virally suppressed', according to new research from UNSW Sydney's Kirby Institute and the global IeDEA consortium, published today in The Lancet HIV.

30 Nov 2021

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

A randomized trial found that video-based, telehealth-delivered exercise and weight loss programs with online educational support improved pain and function in people with knee osteoarthritis and overweight or obesity.

30 Nov 2021

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

30 Nov 2021

Improving access to health care is key to reducing HIV incidence

Many patients living with HIV in rural Africa are not receiving regular treatment, despite recent efforts to increase access to health care across the continent.

30 Nov 2021

Time of starting antiretroviral therapy can influence tumor development In HIV patients

HIV patients have an increased risk of developing skin and mucosal cancers, even though HIV is no longer detectable in their blood due to antiretroviral therapy.

23 Nov 2021

Success of covid antiviral pills hinges on access to speedy and accurate tests

Within a few weeks, perhaps before many Americans finish decorating for the holidays, the U.S. could have access to a new antiviral pill from Merck expected to alter the deadly trajectory of the covid-19 pandemic — with a second option from Pfizer to follow shortly after.

22 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

LSHTM expert comments on NICE approval of first long-acting injectable HIV treatment

NHS watch-dog, the National Institute for Health and Care Excellence (NICE), has published guidance recommending the use of the first long-acting injectable treatment for HIV-1.

18 Nov 2021

Antiretroviral drugs detected in drinking water

Years ago, there was a time that kids from a rural village in South Africa still wanted to swim in the rivers nearby. But when they got out of the water, those with sensitive skins would have the worst rash ever, says Prof Philiswa Nomngongo.

18 Nov 2021

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

INTEGRA’s VOYAGER adjustable tip spacing pipette is supporting crucial experimental work in longitudinal HIV studies.

From INTEGRA Biosciences 12 Nov 2021

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

In a groundbreaking study of people living with HIV, University of Alberta researchers found that elusive white blood cells called neutrophils play a role in impaired T cell functions and counts, as well as the associated chronic inflammation that is common with the virus.

9 Nov 2021

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Research led by scientists at the National Institutes of Health has identified two distinct ways that people with HIV can control the virus for an extended period after stopping antiretroviral therapy (ART) under medical supervision.

29 Oct 2021

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Armed with a novel strategy they developed for bolstering the body's immune response, scientists at Albert Einstein College of Medicine have successfully suppressed HIV infections in mice-;offering a path to a functional cure for HIV and other chronic viral infections.

21 Oct 2021

Antiretroviral News and Research

WHO recommends the use of first long-acting option to protect women from HIV

Study uncovers major disparities in preferred HIV medication uptake in low- and middle-income countries

Scientists identify a new therapeutic target for HIV

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Research finds low global HIV viral suppression rates among children and adolescents

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

Improving access to health care is key to reducing HIV incidence

Time of starting antiretroviral therapy can influence tumor development In HIV patients

Success of covid antiviral pills hinges on access to speedy and accurate tests

First long-acting injectable HIV treatment appraised and approved by NICE

LSHTM expert comments on NICE approval of first long-acting injectable HIV treatment

Antiretroviral drugs detected in drinking water

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

Elusive white blood cells play a role in impaired T cell functions and counts in people with HIV

NIH study identifies distinct mechanisms of long-term HIV control in two people after treatment disruption

Novel Einstein-developed strategy successfully suppresses HIV infections in mice

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

Binghamton professor collaborates on $3.1 million grant to help Black and Latinx youth living with HIV

Chronic COVID-19 and divergent variants of SARS-CoV-2

Exploring the intersection of biology and proteomics

Unlocking the Secrets of Multiple Sclerosis Progression: Brain-Immune Cell Communication

Passing on Polycystic Ovary Syndrome: Health risks for male offspring of women with PCOS

Latest News